Emergent BioSolutions (EBS) 35.43 green arrow $0.83 (2.40%) 08:48AM (15 mins delay)


Description

Emergent BioSolutions Inc. is a biopharmaceutical company focused on the development, manufacture and commercialization of vaccines and immune-related therapeutics that assist the body's immune system to prevent or treat disease. The Company develops vaccines and therapeutics for use against biological agents that are potential weapons of bioterrorism and biowarfare and infectious diseases that have resulted in significant unmet or underserved public health needs. It manufactures and markets BioThrax, also referred to as anthrax vaccine adsorbed, the only vaccine approved by the United States Food and Drug Administration (FDA), for the prevention of anthrax infection. BioThrax is approved for pre-exposure prevention of anthrax infection by all routes of exposure, including inhalation. In addition to the BioThrax product, the Company have product candidates in advanced stages of development and earlier stages of development.

Invite Friends

invite friends to UpDown

Quickly invite a friend below or try our simple tool to invite multiple friends. You earn money when your friends earn.

or invite more friends
sharewise



Make a suggestion for this page